Modulating pain in the periphery: Gene-based therapies to enhance peripheral opioid analgesia: Bonica lecture, ASRA 2010

Research output: Contribution to journalArticle

Abstract

This article provides a brief overview of earlier work of our group on the peripheral signaling of pain, summarizes more recent studies on the role of opioids in chronic neuropathic pain, and speculates on the future of gene-based therapies as novel strategies to enhance the peripheral modulation of pain. Neurophysiologic and psychophysical studies have revealed features of primary afferent activity from somatic tissue that led to improved understanding of the physiology and pathophysiology of pain signaling by nociceptive and nonnociceptive fibers. The demonstration of peripheral opioid mechanisms in neuropathic pain suggests a potential role for these receptors in the modulation of pain at its initiation site. Our work has focused on characterizing this peripheral opioid analgesia in chronic neuropathic pain such that it can be exploited to develop novel and potent peripheral analgesics for its treatment. Ongoing research on virus-mediated gene transfer strategies to enhance peripheral opioid analgesia is presented.

Original languageEnglish (US)
Pages (from-to)210-214
Number of pages5
JournalRegional Anesthesia and Pain Medicine
Volume37
Issue number2
DOIs
StatePublished - Mar 2012

Fingerprint

Genetic Therapy
Analgesia
Opioid Analgesics
Neuralgia
Pain
Chronic Pain
Nociceptive Pain
Analgesics
Viruses
Research
Genes
Therapeutics

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

@article{4301e227fd4d45d6b445afc25fd3c909,
title = "Modulating pain in the periphery: Gene-based therapies to enhance peripheral opioid analgesia: Bonica lecture, ASRA 2010",
abstract = "This article provides a brief overview of earlier work of our group on the peripheral signaling of pain, summarizes more recent studies on the role of opioids in chronic neuropathic pain, and speculates on the future of gene-based therapies as novel strategies to enhance the peripheral modulation of pain. Neurophysiologic and psychophysical studies have revealed features of primary afferent activity from somatic tissue that led to improved understanding of the physiology and pathophysiology of pain signaling by nociceptive and nonnociceptive fibers. The demonstration of peripheral opioid mechanisms in neuropathic pain suggests a potential role for these receptors in the modulation of pain at its initiation site. Our work has focused on characterizing this peripheral opioid analgesia in chronic neuropathic pain such that it can be exploited to develop novel and potent peripheral analgesics for its treatment. Ongoing research on virus-mediated gene transfer strategies to enhance peripheral opioid analgesia is presented.",
author = "Raja, {Srinivasa Naga}",
year = "2012",
month = "3",
doi = "10.1097/AAP.0b013e31823b145f",
language = "English (US)",
volume = "37",
pages = "210--214",
journal = "Regional Anesthesia and Pain Medicine",
issn = "1098-7339",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Modulating pain in the periphery

T2 - Gene-based therapies to enhance peripheral opioid analgesia: Bonica lecture, ASRA 2010

AU - Raja, Srinivasa Naga

PY - 2012/3

Y1 - 2012/3

N2 - This article provides a brief overview of earlier work of our group on the peripheral signaling of pain, summarizes more recent studies on the role of opioids in chronic neuropathic pain, and speculates on the future of gene-based therapies as novel strategies to enhance the peripheral modulation of pain. Neurophysiologic and psychophysical studies have revealed features of primary afferent activity from somatic tissue that led to improved understanding of the physiology and pathophysiology of pain signaling by nociceptive and nonnociceptive fibers. The demonstration of peripheral opioid mechanisms in neuropathic pain suggests a potential role for these receptors in the modulation of pain at its initiation site. Our work has focused on characterizing this peripheral opioid analgesia in chronic neuropathic pain such that it can be exploited to develop novel and potent peripheral analgesics for its treatment. Ongoing research on virus-mediated gene transfer strategies to enhance peripheral opioid analgesia is presented.

AB - This article provides a brief overview of earlier work of our group on the peripheral signaling of pain, summarizes more recent studies on the role of opioids in chronic neuropathic pain, and speculates on the future of gene-based therapies as novel strategies to enhance the peripheral modulation of pain. Neurophysiologic and psychophysical studies have revealed features of primary afferent activity from somatic tissue that led to improved understanding of the physiology and pathophysiology of pain signaling by nociceptive and nonnociceptive fibers. The demonstration of peripheral opioid mechanisms in neuropathic pain suggests a potential role for these receptors in the modulation of pain at its initiation site. Our work has focused on characterizing this peripheral opioid analgesia in chronic neuropathic pain such that it can be exploited to develop novel and potent peripheral analgesics for its treatment. Ongoing research on virus-mediated gene transfer strategies to enhance peripheral opioid analgesia is presented.

UR - http://www.scopus.com/inward/record.url?scp=84859774496&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859774496&partnerID=8YFLogxK

U2 - 10.1097/AAP.0b013e31823b145f

DO - 10.1097/AAP.0b013e31823b145f

M3 - Article

C2 - 22189620

AN - SCOPUS:84859774496

VL - 37

SP - 210

EP - 214

JO - Regional Anesthesia and Pain Medicine

JF - Regional Anesthesia and Pain Medicine

SN - 1098-7339

IS - 2

ER -